Galleri Blood Test Draws No Major Safety Questions From FDA Staff, but It Missed Most Stage I Cancers

FDA reviewers raised no major safety questions about the Galleri cancer blood test, but the agency’s own data show it missed most stage I cancers.

Have A Referral?